Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Akcea Therapeutics, Inc.    AKCA

AKCEA THERAPEUTICS, INC.

(AKCA)
  Report
SummaryQuotesChartsNewsRatingsCompanyFinancials 
 SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
Most relevant news about AKCEA THERAPEUTICS, INC.
10/12AKCEA THERAPEUTICS : Ionis Pharmaceuticals completes acquisition of Akcea Therap..
PR
09/18AKCEA THERAPEUTICS : WAYLIVRA▼® (volanesorsen), the First and Only Therapy..
BU
09/11WeissLaw LLP Reminds AKCA and AIMT Shareholders About Its Ongoing Investigati..
PR
09/05KASKELA LAW LLC : Announces Stockholder Investigation of Akcea Therapeutics, Inc..
PR
09/04AKCEA INVESTOR ALERT BY THE FORMER A : Kahn Swick & Foti, LLC Investigates Adequ..
BU
09/01Monteverde & Associates PC Announces an Investigation of Akcea Therapeutics, ..
PR
08/31AKCEA THERAPEUTICS : Ionis Pharmaceuticals to acquire remaining stake in Akcea T..
PR
08/25AKCEA THERAPEUTICS : and Ionis to Present Phase 2 Clinical Data of Vupanorsen at..
AQ
08/14AKCEA THERAPEUTICS : Announces New Pricing and Reimbursement of WAYLIVRA in Germ..
AQ
08/04AKCEA THERAPEUTICS : 2Q Earnings Snapshot
AQ
08/04AKCEA THERAPEUTICS : Reports Financial Results and Highlights for Second Quarter..
PR
07/23AKCEA THERAPEUTICS : Announces Approval for Reimbursement of TEGSEDI in Austria ..
AQ
07/22AKCEA THERAPEUTICS : Announces Approval for Reimbursement of TEGSEDI® (inotersen..
PR
07/21AKCEA THERAPEUTICS : Appoints New Senior Vice President, Global Medical Affairs
AQ
06/29AKCEA THERAPEUTICS : Appoints Tracy Palmer Berns as Chief Compliance Officer
PR
More most relevant news
All news about AKCEA THERAPEUTICS, INC.
11/10IONIS PHARMACEUTICALS : Akcea Therapeutics - WAYLIVRA, the first and only therap..
AQ
11/09IONIS PHARMACEUTICALS : and Akcea Recognize FCS Awareness Day with Global Commun..
AQ
11/04IONIS PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
AQ
11/04Ionis and Akcea announce that Pfizer has initiated a Phase 2b clinical study ..
AQ
11/02IONIS PHARMACEUTICALS : and Akcea win prestigious Prix Galien Award for TEGSEDI ..
AQ
10/13IONIS PHARMACEUTICALS : completes acquisition of Akcea Therapeutics
AQ
10/13AKCEA THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Notice of..
AQ
10/13IONIS PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, ..
AQ
10/12AKCEA THERAPEUTICS : Ionis Pharmaceuticals completes acquisition of Akcea Therap..
PR
09/18AKCEA THERAPEUTICS : WAYLIVRA▼® (volanesorsen), the First and Only Therapy..
BU
More news
News in other languages on AKCEA THERAPEUTICS, INC.
2019AKCEA THERAPEUTICS INC : Veröffentlichung des Jahresergebnisses
2019AKCEA THERAPEUTICS INC : publication des résultats annuels
Press releases
11/10IONIS PHARMACEUTICALS : Akcea Therapeutics - WAYLIVRA, the first and only therap..
AQ
11/09IONIS PHARMACEUTICALS : and Akcea Recognize FCS Awareness Day with Global Commun..
AQ
11/04IONIS PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
AQ
11/04Ionis and Akcea announce that Pfizer has initiated a Phase 2b clinical study ..
AQ
11/02IONIS PHARMACEUTICALS : and Akcea win prestigious Prix Galien Award for TEGSEDI ..
AQ
More press releases